DVY vs XLV
iShares Select Dividend ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.38% for DVY.
- • DVY pays a higher dividend yield (3.29%).
Side-by-side metrics
| Metric | DVY | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.38% | 0.08% |
Dividend yield Trailing 12-month yield. | 3.29% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $23.69B | $49.10B |
YTD return | 17.74% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.51 | 0.41 |
P/E ratio | 14.69 | 30.63 |
Last price | $162.67 | $187.94 |
Inception | — | — |
Issuer | iShares | State Street |
DVY top holdings
| PFE | Pfizer Inc | 2.46% |
| MO | Altria Group Inc | 2.38% |
| HPQ | HP Inc | 2.16% |
| PRU | Prudential Financial Inc | 2.12% |
| TROW | T. Rowe Price Group Inc | 1.99% |
| OKE | ONEOK Inc | 1.84% |
| TGT | Target Corp | 1.68% |
| VZ | Verizon Communications Inc | 1.66% |
| CVX | Chevron Corp | 1.62% |
| KMB | Kimberly-Clark Corp | 1.61% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About DVY
DVY (iShares Select Dividend ETF) is 100 high-dividend-yielding US stocks. Managed by iShares, the fund carries $23.7B in assets under management, an expense ratio of 0.38%, a dividend yield of 3.29%. Its largest holding is Pfizer Inc (PFE), which represents 2.5% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 9.8%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.